These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Mechanism of preventing the recurrence of bladder carcinoma by intravesical instillation of BCG plus IL-2].
    Author: Wen R, Zhou G, Xie S, Lian B, Sun X, Chen J.
    Journal: Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):247-8. PubMed ID: 11825381.
    Abstract:
    OBJECTIVE: To study the mechanism of preventing the recurrence of bladder carcinoma by intravesical instillation of BCG plus IL-2. METHOD: Intravesical instillation of BCG or BCG plus IL-2 were carried out in the bladder transitional cell carcinoma patients undergoing surgical operation (16, 19 cases respectively). RESULT: They were followed up for 14-22 months. The recurrence rates were 31.25% and 21.05% respectively. At 6 weeks after the instillation of IL-2 plus BCG, the peripheral blood NKCF activity was increased significantly and there was a significant positive correlation between the activities of NKCF and IL-2. CONCLUSION: The intravesical instillation of IL-2 plus BCG is clearly superior to only BCG in preventing recurrence of bladder carcinoma. There may be immuno-enhancement and immuno-synergism.
    [Abstract] [Full Text] [Related] [New Search]